FDA clears wearable Sarclisa as HHS advances antidepressant deprescribing

The U.S. drug regulation and health policy environment produced two distinct signals for the pharmaceutical sector in close succession. The Food and Drug Administration approved a wearable formulation of Sanofi's multiple myeloma…